Millennium Management’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Millennium Management’s Portfolio CRXT Stock Details CRXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-170,520	Closed	-$65K	–	7802
2022 Q2	$65K	Buy	170,520 +131,292	+335%	+$91.9K	﹤0.01%	6095
2022 Q1	$58K	Buy	+39,228	New	+$49.8K	﹤0.01%	6359
2021 Q3	–	Sell	-56,987	Closed	-$574K	–	7502
2021 Q2	$574K	Buy	+56,987	New	+$574K	﹤0.01%	5182

Other funds holding CRXT

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Millennium Management's CRXT Position: Q3 2022 in Review

Millennium Management sold out of Clarus Therapeutics Holdings, Inc. Common Stock (CRXT) in Q3 2022, closing a stake of 170,520 shares — an estimated $65K sold.

Millennium Management first reported a position in CRXT in Q2 2021 and held it in 3 quarters. The position peaked at $574K in Q2 2021. 2 funds tracked by Wall St. Rank hold CRXT as of Q3 2022.

Millennium Management reported no remaining Clarus Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Millennium Management sold 170,520 Clarus Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $65K.
Millennium Management first reported a position in Clarus Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
Millennium Management's Clarus Therapeutics Holdings, Inc. Common Stock position peaked at $574K in Q2 2021.
2 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.